Potassium Chloride Extended Release Tablets

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on October 16, 2025.

Award Information

This solicitation resulted in an award to for approximately $39,510,149 on October 16, 2025. Similar contracts are typically issued by DEPT OF DEFENSE under 325412 (Pharmaceutical Preparation Manufacturing).

Award Number: SPE2D2-26-D-0001
Award Amount: $39,510,149
Award Date: October 16, 2025

View full award details on USASpending.gov

Key Takeaways

No response deadline specified - contact the agency for details
Set-aside for No Set Aside businesses
Work to be performed in PHILADELPHIA, PA
Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID: SPE2D2-26-D-0001
Opportunity Type: Award Notice
Agency: DEPT OF DEFENSE
Sub-Agency: DEFENSE LOGISTICS AGENCY
Office: DLA TROOP SUPPORT
Posted Date: Thursday, March 19, 2026
Response Deadline: Not specified
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
PSC Code: 6505
Set-Aside: No Set Aside
Place of Performance: PHILADELPHIA, PA, 19111
Status: Active

View on SAM.gov

Description

SPE2D2-26-D-0001 Potassium Chloride ER Tablets

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for pharmaceutical preparation manufacturing with a set-aside for No Set Aside businesses in PHILADELPHIA, PA. This set-aside designation means eligible businesses face reduced competition from larger firms.

Similar Opportunities

Potassium Chloride Extended Release Tablets

Award Information

Key Takeaways

Contract Details

Description

Why This Opportunity Matters

Similar Opportunities

6505-VASD PSMA

Alendronate Sodium Tablets

Celecoxib Capsules

6505-Dimethyl Fumarate Capsules

6505-XERIS PHARMACEUTICALS, INC 65IB 36F79726D0087 04/01/2026 03/31/2031

Browse Related